IPP Bureau
Lessons from COVID management valuable beacons for cancer prevention and treatment: Union Health Secretary
By IPP Bureau - August 24, 2022
The pandemic has taught us that health is not the exclusive responsibility of only the Union Health Ministry but jointly addressed by various Ministries at the centre and through state governments
Glenmark receives OAI communication from US FDA
By IPP Bureau - August 24, 2022
The company continues to cooperate with the US FDA and is committed to undertake all necessary steps required to address their observations at the earliest
Unichem Laboratories receives ANDA approval for Carbamazepine Tablets
By IPP Bureau - August 24, 2022
Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
Jaslok Hospital launches coordination center in Oman
By IPP Bureau - August 24, 2022
The citizens of Oman will soon have a coordination center that will provide end to end services for healthcare facilities of Jaslok.
Eugia Pharma receives USFDA pproval for Medroxyprogesterone Acetate injectable suspension
By IPP Bureau - August 24, 2022
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
Celanese announces Grant Award to develop refillable drug delivery solution
By IPP Bureau - August 24, 2022
Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation
Arsenal Capital raises $5.4 billion for two new funds
By IPP Bureau - August 23, 2022
Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers
Lonza introduces X-ray powder diffraction at Monteggio
By IPP Bureau - August 23, 2022
This rapid analytical technique provides additional information about the polymorph and solid-state properties of active pharmaceutical ingredients (APIs)
Health Minister Mandaviya addresses Bharat Swaasth Mahotsav
By IPP Bureau - August 23, 2022
Bharat Swasth Mahotsav organises ‘Padma Doctors Congregation’ for Celebrating Healthcare Changemakers in India Since Independence
Dr. Jitendra Singh announces 75 Amrit Grants for biotech initiatives
By IPP Bureau - August 23, 2022
75 inter-disciplinary, multi-institutional grants would be supported for high-risk, ambitious research ideas, milestones-driven collaborative research in all domain areas of the biotech sector
PM to inaugurate Amrita Hospital and Homi Bhabha Cancer Hospital & Research Centre
By IPP Bureau - August 23, 2022
The hospital is being constructed at an estimated cost of around Rs. 6,000 crore and will provide healthcare facilities to the people of Faridabad and the entire NCR region
PGIMER Satellite Centre to be functional by Jan 2023: Dr. Mandaviya
By IPP Bureau - August 22, 2022
Phase 1 has already been executed with the construction of temporary OPD, guest house and boundary wall and Phase 2 of the execution is being fast tracked
Wockhardt signs USFDA approved manufacturing partners
By IPP Bureau - August 22, 2022
The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner
8th edition of Indo-Japanese Chronic Total Occlusion (IJCTO) summit concluded successfully
By IPP Bureau - August 22, 2022
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
USFDA grants emergency use authorization for Novavax COVID-19 vaccine
By IPP Bureau - August 22, 2022
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
